PERK-IN-5 is a potent, highly selective, and orally bioavailable inhibitor of protein kinase R-like endoplasmic reticulum kinase (PERK), with IC50 values of 2 nM and 9 nM for PERK and p-eIF2α, respectively; it significantly inhibits tumor growth in the 786-O renal cell carcinoma xenograft model.